Cita APA (7a ed.)

Croucher, P., Hijzen, A., Shipman, C., Perry, M., Lippitt, J., Green, J., . . . Vanderkerken, K. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.

Cita Chicago Style (17a ed.)

Croucher, P., A. Hijzen, C. Shipman, M. Perry, J. Lippitt, J. Green, B. Van Camp, y K. Vanderkerken. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.

Cita MLA (9a ed.)

Croucher, P., et al. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.